However, in the present study, we mainly focused on investigating the correlation between CpG methylation in genome and response to PD-1 or PD-L1 therapy and predicting ORR of cancer based on methylation level of several CpG sites in the patients. This evidence concerns the gene PDCD1 and cancer.